Page 2 - Anders Gaarsdal Holst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anders gaarsdal holst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anders Gaarsdal Holst Today - Breaking & Trending Today

Positive data for Acesion's atrial fibrillation candidates

The company intends to advance AF drugs that address current risk concerns with existing therapies - News - PharmaTimes ....

Anders Gaarsdal Holst , Acesion Pharma , Gaarsdal Holst , Acesion ,

Acesion Pharma Announces Positive Pre-Clinical Data for AP31969

/PRNewswire/ Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering first-in-class novel therapies for atrial fibrillation ("AF"), the. ....

Anders Gaarsdal Holst , Prnewswire Acesion Pharma , Acesion Pharma , Novo Holdings , Gaarsdal Holst , Chief Executive Officerof Acesion , Wellcome Trust , Broadview Ventures , New England Journal ,

Acesion Pharma developing AF drug without safety issues

A company says it is developing a small molecule drug without major safety issues to treat a growing number of cases of atrial fibrillation, the most common cardiac arrhythmia. ....

Acesion Pharma , Anders Gaarsdal Holst , Gaarsdal Holst , Preclinical Research , Cardiovascular Disease , Acesion Pharma , Trial Defibrillation ,

Acesion announces positive atrial fibrillation study

Candidate AP30663 is an inhibitor for the conversion of atrial fibrillation to a normal sinus rhythm - News - PharmaTimes ....

John Camm , Acesion Pharma , Anders Gaarsdal Holst , St George University Of London , Gaarsdal Holst , Acesion , Atrial Fibrillation ,

Acesion Pharma announces positive phase 2 data from Atrial Fibrillation clinical trial

/PRNewswire/ Acesion Pharma ("Acesion"), the biotech pioneering first-in-class novel therapies for Atrial Fibrillation ("AF"), the most common cardiac. ....

A John Camm , Acesion Pharma , Anders Gaarsdal Holst , George University Of London , Novo Holdings , Atrial Fibrillation , Gaarsdal Holst , Chief Executive Officer , John Camm , Emeritus Professor , Clinical Cardiology , Wellcome Trust , Broadview Ventures , New England Journal ,